|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 334.90 CHF | -1.35% |
|
+2.01% | +2.04% |
| Jul. 15 | Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns | MT |
| Jul. 15 | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 344.7 | 374 | 367.8 |
| Spread/Res. | -2.84% | -10.45% | -8.95% |
| Spread/Supp. | +5.25% | +8.95% | +10.40% |
| Support | 318.2 | 307.4 | 303.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ROP Stock
- ROG Stock
- Charts Roche Holding AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
